(Q36066305)

12 August 2017

1 reference

title

New targets in the treatment of anorexia nervosa (English)

1 reference

12 August 2017

0 references

James Edward Mitchell

series ordinal

2

object named as

James E Mitchell

1 reference

12 August 2017

James L Roerig

1

1 reference

12 August 2017

Kristine J Steffen

series ordinal

3

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 February 2005

1 reference

Expert Opinion on Therapeutic Targets

12 August 2017

published in

1 reference

12 August 2017

volume

9

1 reference

12 August 2017

issue

1

1 reference

12 August 2017

page(s)

135-151

1 reference

Report of the National Institutes of Health workshop on overcoming barriers to treatment research in anorexia nervosa

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Neurotransmitter and imaging studies in anorexia nervosa: new targets for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Personality and symptomatological features in young, nonchronic anorexia nervosa patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Comorbidity of psychiatric diagnoses in anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Depressive disorders in teenage-onset anorexia nervosa: a controlled longitudinal, partly community-based study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Eating disorders and antecedent anxiety disorders: a controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Anxiety disorders in anorexia nervosa and bulimia nervosa: co-morbidity and chronology of appearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Treatment resistance in anorexia nervosa and the pervasiveness of ethics in clinical decision making.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

21 January 2018

Serotonin and appetite

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Toward a unified theory of serotonin dysregulation in eating and related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

CSF 5-HIAA concentrations in anorexia nervosa: reduced values in underweight subjects normalize after weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Behavioral and neuroendocrine responses to metaCPP in anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Reduced 5-HT2A receptor binding after recovery from anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Altered response to meta-chlorophenylpiperazine in anorexia nervosa: support for a persistent alteration of serotonin activity after short-term weight restoration

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Anxiolytic effects of acute tryptophan depletion in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Serotonin (1A) receptor ligands act on norepinephrine neuron firing through excitatory amino acid and GABA(A) receptors: a microiontophoretic study in the rat locus coeruleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Use of nutritional supplements to increase the efficacy of fluoxetine in the treatment of anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Changes in brain levels of acidic, basic, and neutral amino acids after consumption of single meals containing various proportions of protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Histamine formation in rat brain in vivo: effects of histidine loads

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Changes in the feeding behavior of rats elicited by histamine infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Food intake suppression by histidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Is monoamine turnover in the brain regulated by histamine H3 receptors?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Differences in nitrogen metabolism between protein-deficient and energy-deficient rats with similarly restricted growth rates.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Atypical antipsychotics and weight gain--a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Bodyweight gain with atypical antipsychotics. A comparative review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

H1-histamine receptor affinity predicts short-term weight gain for typical and atypical antipsychotic drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Pharmacogenetics of antipsychotic-induced weight gain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Long-term neuroleptic therapy in chronic anorexia nervosa complicated by tardive dyskinesia. A case report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Atypical antipsychotic drugs improve cognition in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

The neurocognitive effects of low-dose haloperidol: a two-year comparison with risperidone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Another view of therapy for cognition in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Comparative effect of atypical and conventional antipsychotic drugs on neurocognition in first-episode psychosis: a randomized, double-blind trial of olanzapine versus low doses of haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Six-month open trial of haloperidol as an adjunctive treatment for anorexia nervosa: a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Double-blind placebo-controlled administration of fluoxetine in restricting- and restricting-purging-type anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

The neurobiological basis of eating disorders: some formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

A review of endocrine changes in anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Characterization of a 41-Residue Ovine Hypothalamic Peptide That Stimulates Secretion of Corticotropin and β-Endorphin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

The hypothalamic-pituitary-adrenal axis in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Hypothalamic-pituitary-adrenal-cortical activity in anorexia nervosa and bulimia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Corticotropin releasing factor produces behavioural activation in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Effects of the high-affinity corticotropin-releasing hormone receptor 1 antagonist R121919 in major depression: the first 20 patients treated

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Pathways to the secretion of adrenocorticotropin: a view from the portal*.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Measurement of CSF dynorphin a 1–8 immunoreactivity in anorexia nervosa and normal-weight bulimia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

T-lymphocyte cholecystokinin-8 and beta-endorphin concentrations in eating disorders: I. Anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Structure-function analysis of stimulation of food intake by neuropeptide Y: Effects of receptor agonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

To eat or not to eat - how the gut talks to the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Gut hormone PYY(3-36) physiologically inhibits food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Inhibition of food intake in obese subjects by peptide YY3-36

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Neurosteroid metabolism in the human brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Roles for ghrelin in the regulation of appetite and body weight

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Subtypes Y1 and Y2 of the neuropeptide Y receptor are respectively expressed in pro-opiomelanocortin- and neuropeptide-Y-containing neurons of the rat hypothalamic arcuate nucleus

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans. Implications for the physiology of CCK.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Regulation of gastric emptying in humans by cholecystokinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Changes in plasma cholecystokinin concentrations after oral glucose tolerance test in anorexia nervosa before and after therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Cholecystokinin, vasoactive intestinal peptide and peptide histidine methionine responses to feeding in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Physiology of the control of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Satiety effects of the type A CCK receptor antagonist loxiglumide in lean and obese women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Positional cloning of the mouse obese gene and its human homologue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Effects of the obese gene product on body weight regulation in ob/ob mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Weight-reducing effects of the plasma protein encoded by the obese gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Recombinant mouse OB protein: evidence for a peripheral signal linking adiposity and central neural networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Congenital leptin deficiency is associated with severe early-onset obesity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

The hypothalamic leptin receptor in humans: identification of incidental sequence polymorphisms and absence of the db/db mouse and fa/fa rat mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Serum immunoreactive-leptin concentrations in normal-weight and obese humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Pronounced early increase in circulating leptin predicts a lower weight gain during clozapine treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Leptin in anorexia nervosa and bulimia nervosa: importance of assay technique and method of interpretation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

High serum leptin levels subsequent to weight gain predict renewed weight loss in patients with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Leptin, neuropeptide Y, and peptide YY in long-term recovered eating disorder patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Recent developments in our understanding of melanocortin system in the regulation of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Role of melanocortinergic neurons in feeding and the agouti obesity syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Neuroendocrine interactions between galanin, opioids, and neuropeptide Y in the control of reproduction and appetite

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

The role of galanin in feeding behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Could reduced cerebrospinal fluid (csf) galanin contribute to restricted eating in anorexia nervosa?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Galanin immunoreactivity in human CSF: studies in eating disorders and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Disturbed release of gastrointestinal peptides in anorexia nervosa and in obesity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Isolation and structure of bombesin and alytesin, two analogous active peptides from the skin of the european amphibiansBombina andAlytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Characterization of a gastrin releasing peptide from porcine non-antral gastric tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Neuromedin B: a novel bombesin-like peptide identified in porcine spinal cord

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Bombesin and its family of peptides: prospects for the treatment of obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Role of bombesin-related peptides in the control of food intake

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Effects of Sibutramine on Binge Eating, Hunger, and Fullness in a Laboratory Human Feeding Paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Case study: anorexia nervosa and autistic disorder in an adolescent girl.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Case reports of olanzapine treatment of anorexia nervosa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Olanzapine in children and adolescents with chronic anorexia nervosa. A study of five cases

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

A single blind comparison of amisulpride, fluoxetine and clomipramine in the treatment of restricting anorectics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Olanzapine in the treatment of anorexia nervosa: an open label trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Olanzapine use as an adjunctive treatment for hospitalized children with anorexia nervosa: case reports

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Olanzapine in anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Olanzapine treatment of an adolescent girl with anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Olanzapine treatment of anorexia nervosa: a retrospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Major Affective Disorder in Anorexia Nervosa and Bulimia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Leptin suppresses semi-starvation induced hyperactivity in rats: implications for anorexia nervosa

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

Bombesin suppresses feeding in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14728222.9.1.135

21 January 2018

Identifiers

DOI

10.1517/14728222.9.1.135

1 reference

12 August 2017

1 reference